- Use of anti-VEGF drugs in ophthalmology2019 | Faculty of Medicine in Hradec Králové
- Brolucizumab - A New Player In The Field Of Anti-VEGF Therapy Of Neovascular Age-Related Macular Degeneration. A Review2022 | First Faculty of Medicine
- Molecular profiling of the regeneration process in spinal cord injury after VEGF and NGF plasmid injectionPublication without faculty affiliation
- TPS, Thymidine Kinase, VEGF and Endostatin in Cytosol of Thyroid Tissue Samples2005 | First Faculty of Medicine
- Efficacy of anti-VEGF therapy (aflibercept) in advanced colorectal cancer2019 | Publication without faculty affiliation
- TPS, Thymidine Kinase, VEGF and Endostatin in Cytosol of Thyroid Tissue Samples2005 | Faculty of Medicine in Hradec Králové
- Today's view of the origin, evolution and treatment of retinopathy of prematurity2016 | Second Faculty of Medicine
- Vascular endothelial growth factor in ovarian cancer patients2012 | Faculty of Medicine in Hradec Králové
- Význam biomarkerů pro léčbu anti-VEGF inhibitory a jejíí účinnost u metastatického kolorekt álního karcinomu2018 | Publication without faculty affiliation
- Side effects of targeted treatment with EGFR and VEGF inhibitors2015 | Second Faculty of Medicine
- The importance of angiogenesis for the growth of ovarian cancer and the impact of bevacizumab2014 | Faculty of Medicine in Hradec Králové
- Regeneration of the Intraspinal Plasticity Induced by VEGF and NGF PlasmidPublication without faculty affiliation
- VEGF: A key player not only in macular generation. A review2020 | Third Faculty of Medicine
- Tissue repair driven by two different mechanisms of growth factor plasmids VEGF and NGF in mice auricular cartilage: regeneration mediated by administering growth factor plasmids2012 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Research Report University Hospital for clinical assessment BAY 86-5321 / 91745Publication without faculty affiliation
- Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease2008 | First Faculty of Medicine
- Plasma concetrations of vascular endothelial growth factor and basic fibroblast growth factor in lymphoproliferative disorders2005 | Publication without faculty affiliation
- Plasma concetrations of vascular endothelial growth factor and basic fibroblast growth factor in lymphoproliferative disorders2005 | First Faculty of Medicine
- Plasma concentrations of angiogenic activators bFGF and VEGF measured by ELISA inPublication without faculty affiliation
- PARP inhibitor olaparib and anti-VEGF bevacizumab - targeted treatment and efforts to improve the outcome of patients with advanced tuboovarian cancer2020 | Faculty of Medicine in Pilsen
- From SARS-CoV-2 to analgesia: harnessing the VEGF-A/NRP-1 axis for pain therapy2023 | Third Faculty of Medicine
- Angiogenic factors bFGF, VEGF and sCD105 are elevated in B-cell chronic lymphocytic +1Publication without faculty affiliation
- Antiangiogenic therapy for ovarian cancer2013 | First Faculty of Medicine
- Kardiovaskulární nežádoucí účinky anti-VEGF terapie v onkologii2021 | Third Faculty of Medicine
- Age-related macular degeneration2018 | Faculty of Medicine in Hradec Králové
- Correlations of EGFR and VEGF expression with toxicity of postoperative adjuvant radiochemotherapy for rectal adenocarcinoma - a pilot studyPublication without faculty affiliation
- Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma2015 | Faculty of Medicine in Pilsen
- Time-profile kinetics of serum VEGF, IL-6, and MCP-1 in traumatic brain injuryPublication without faculty affiliation
- Proteinuria and Hypertension in Patients Treated with Inhibitors of the VEGF Signalling Pathway - Incidence, Mechanisms and Management2013 | First Faculty of Medicine